oral semaglutide cardiovascular outcomes soul trial results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Canadian Perspectives 2025 Whiteboard on

Improved glycaemic control from Wegovy may actually reduce yeast infection risk over time in patients with diabetes

Ive spoken to many people who are nervous about injections

If side effects become bothersome or severe, healthcare providers may adjust the dosage or consider alternative treatment options

In this method, high-quality eggs are taken from another person and, after fertilization with the partners sperm, are transferred to the recipients uterus

This vascular limitation explains why conventional treatments often fall short

Therefore it was posited to be the result of an increase in muscle tissues and water retention